In addition, we performed qRT-PCR analysis on clinical specimens and found that the mRNA expression levels of FGF17, PRKCG, and SSTR1 were significantly different between kidney cancer tissues and normal tissues adjacent to the cancer. This evidence concerns the gene FGF17 and kidney cancer.